Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001136261-20-000006
Filing Date
2020-01-03
Accepted
2020-01-03 16:32:45
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 body424b5.htm 424B5 163968
2 LOGO apricuslogoa02aa01.jpg GRAPHIC 98278
3 LOGO image3867.gif GRAPHIC 5790
  Complete submission text file 0001136261-20-000006.txt   308183
Mailing Address 300 PARK AVENUE NEW YORK NY 10017
Business Address 300 PARK AVENUE NEW YORK NY 10017 (646) 998-6475
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-221285 | Film No.: 20505990
SIC: 2834 Pharmaceutical Preparations